Table 4 Impact of the PLIN rs894160 SNP on clinical variables in men and women separately
From: Study of the impact of perilipin polymorphisms in a French population
Men | Women | |||||
|---|---|---|---|---|---|---|
GG 281 | GA 235 | AA 54 | GG 272 | GA 231 | AA 39 | |
Weight, kg | 80.2 ± 14.1 | 79.2 ± 12.8 | 81.1 ± 13.2 | 67.5 ± 14.1 | 69.9 ± 14.6 | 67.9 ± 16.8 |
BMI, kg/m2 | 26.9 ± 4.3 | 26.3 ± 4.0 | 26.3 ± 3.7 | 26.2 ± 5.3 | 27.0 ± 5.4 | 26.7 ± 7.1 |
Waist, cm | 96.5 ± 11.4 | 95.5 ± 10.2 | 96.3 ± 10.3 | 84.7 ± 13.4 | 87.0 ± 14.1 | 84.3 ± 16.9 |
Hip circ., cm | 101.7 ± 7.5 | 101.4 ± 7.3 | 101.4 ± 7.1 | 102.9 ± 11.1 | 104.6 ± 11.8 | 103.7 ± 15.5 |
WHR | 0.95 ± 0.07 | 0.94 ± 0.07 | 0.95 ± 0.07 | 0.82 ± 0.08 | 0.83 ± 0.08 | 0.81 ± 0.07 |
Leptin, ng/mL† | 9.60 ± 7.90 | 9.18 ± 7.55 | 8.24 ± 6.19 | 23.12 ± 13.72 | 25.26 ± 14.52 | 23.79 ± 13.28 |
Cholesterol, mmol/L | 5.93 ± 1.10 | 5.83 ± 1.00 | 5.86 ± 0.90 | 5.90 ± 1.18 | 6.01 ± 1.05 | 5.93 ± 1.11 |
HDL-chol., mmol/L | 1.33 ± 0.41 | 1.37 ± 0.41 | 1.24 ± 0.37 | 1.65 ± 0.51 | 1.68 ± 0.47 | 1.69 ± 0.43 |
LDL-chol., mmol/L | 3.90 ± 1.05 | 3.79 ± 0.96 | 3.99 ± 0.85 | 3.69 ± 1.10 | 3.80 ± 0.99 | 3.68 ± 1.05 |
Triglycerides, mmol/L† | 1.71 ± 1.42 | 1.57 ± 1.31 | 1.68 ± 1.66 | 1.21 ± 0.87 | 1.19 ± 0.97 | 1.16 ± 0.77 |
Glucose, mmol/L† | 5.56 ± 0.90 | 5.49 ± 0.85 | 5.27 ± 0.64* | 5.40 ± 1.41 | 5.42 ± 1.71 | 5.64 ± 1.55 |
Insulin, μU/mL† | 12.52 ± 9.48 | 11.93 ± 8.16 | 12.83 ± 13.62 | 11.47 ± 5.86 | 11.83 ± 5.87 | 12.43 ± 7.32 |